CLINICAL_TRIALS
trial_result
· 2016-06-07
Clinical Trial Update: Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts [NA]
Summary
The study evaluating ultralow-dose computed tomography for high-risk contacts of drug-resistant tuberculosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Seoul National University Hospital | Conditions: Latent Tuberculosis | NA | Status: COMPLETED